ALIT LifeTech provides advanced instruments, high-quality reagents and consumables, and dependable services to the life science and biotherapeutic industry. Through continued technological innovations, we have developed a comprehensive suite of laboratory instruments and manufacturing equipment to support our customers from R&D to manufacturing.
In addition to the industry leading Countstar cell analyzers, our novel bioprocessing equipment and automated 3D organoid culture system have supported scientists in advancing life science research or developing next generation therapeutics throughout academic labs, government institutes, and biopharmaceutical companies.
We are committed to continued technology innovation and strive to be the world leader in serving science. Our mission is to enable our customers to make the world healthier and happier.
Company Details
- Employees
- 8
- Founded
- -
- Address
- Boston, Ma 02115, Us
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://alitlifetech.com/
- Keywords
- Cell Counting, Organoid Culture, High-throughput cell analysis, high-throughput organoid analysis, Cell Viability, organoid analysis.
- HQ
- Boston, MA
Alit Lifetech Questions
Alit Lifetech's website is https://alitlifetech.com/
Alit Lifetech's LinkedIn profile is https://www.linkedin.com/company/alit-lifetech
Alit Lifetech has
8 employees.
View email and phone details for 8
employees at Alit Lifetech.
Alit Lifetech's industry is
Research Services
Alit Lifetech's top competitors are
Thermo Fisher Scientific,
Biolabs@nyulangone,
Biolabs At The Lundquist Institute,
Akoya Biosciences, Inc.,
Logos Biosystems,
Regcell,
Countstar Automated Cell Counter,
Harper Wilde,
Bioauxilium,
Vera Therapeutics, Inc..
Alit Lifetech's categories are Research Services
Alit Lifetech's founding year is 2023
